Journal of Neuro-Oncology

Article	Citations
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas	66
A practical guide to neuro-oncology fellowship	55
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence	54
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease	47
Prognostic factors among patients with brain metastases from cancer of unknown primary site	46
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma	42
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study	42
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas	41
Factors influencing timely diagnosis in neurolymphomatosis	40
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection	39
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	34
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy	34
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline	33
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases	33
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis	31
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis	30
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases	30
Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review	30
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab	30
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study	29
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases	29
The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management	28
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic review	28
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival	28
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma	27

Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population	27
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu	27
Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities	26
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor	26
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience	25
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival	25
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review	24
Comment on: “Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma”	24
Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgery	24
Multimodal pathomics and clinical features predict postresection permanent hydrocephalus in pediatric medulloblastoma	23
Glioblastoma cell motility and invasion is regulated by membrane-associated heat shock protein Hsp70	23
Focused versus conventional radiotherapy in spinal oncology: is there any difference in fusion rates and pseudoarthrosis?	23
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update	23
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma	22
Patterns of response following gamma knife radiosurgery for tectal plate gliomas	21
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience	21
Journal of Neuro-Oncology, Meningioma issue	21
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors	20
Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection	20
Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024	20
Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis	20
Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer	20
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses	20
Predicting post-surgical functional status in high-grade glioma with resting state fMRI and machine learning	20
Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5– a case series	20
Early and late structural brain changes after radiation therapy: an MRI study in glioma patients	20
Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme	19
Correction to: Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data	19
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients	19
Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy	19
The use of telemedicine in pre-surgical evaluation: a retrospective cohort study of a neurosurgical oncology practice	19
Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?	19
Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence	19
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice	19
The concept, intention, and evaluation of the term treatment-refractory meningioma	18
The role of spine stereotactic radiosurgery for patients with breast cancer metastases	18
Brain metastases from ovarian cancer: neuroradiological profile and survival overview of neurosurgical cases	18
Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44	18
The evolving role of reirradiation in the management of recurrent brain tumors	18
Chemotherapy is an efficient treatment in primary CNS MALT lymphoma	18
The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour	18
Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey	18
Correction to: A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases	18
NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis	17
Genome-wide association study on meningioma risk in Japan: a multicenter prospective study	17
Postoperative CT scans after resection of brain metastases: neurosurgical routine or added value?	17
Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation	17
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT	17
Preoperative assessment of eloquence in neurosurgery: a systematic review	17
AANS/CNS Endorsement	17

Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control	17
Management and treatment of brain tumors during pregnancy: an Italian survey	17
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases	17
Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis	17
The posterior fossa syndrome questionnaire: using science to inform practice	17
First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound	17
Raman and autofluorescence spectroscopy for in situ identification of neoplastic tissue during surgical treatment of brain tumors	17
Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China	17
Is H3 K27M mutation testing relevant in the diagnostic routine of WHO grade 4 gliomas exclusively located in the corpus callosum in adults?	16
Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-β/Smad signal pathway	16
Diagnostic value of 18F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients	16
Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation: insights from transcriptomic and proteomic analysis	16
Comment on “The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management”	16
Correction to: Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study	16
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors	16
Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery	16
Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysis	16
Repurposing mebendazole against triple-negative breast cancer CNS metastasis	16
High dose image-guided, intensity modulated radiation therapy (IG-IMRT) for chordomas of the sacrum, mobile spine and skull base: preliminary outcomes	16
Risk calculator for long-term survival prediction of spinal chordoma versus chondrosarcoma: a nationwide analysis	16
Radiotherapeutic advances in the management of glioblastoma	16
Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma	16
Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator	16
Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma	16
The Journal of Neuro-Oncology: the last and next 40 years	15
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update	15
Circadian variation in MGMT promoter methylation and expression predicts sensitivity to temozolomide in glioblastoma	15
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression	15
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches	15
The state of art of awake craniotomy in Latin American countries: a scoping review	15
The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials	15
IDH1 mutation is associated with improved resection rates, progression-free survival and overall survival in patients with anaplastic astrocytomas	15
Low tumour burden is associated with observation after surgery in patients with grade 2 astrocytoma and oligodendroglioma: results from the prospective multicentre LoG-Glio registry	15
Stereotactic radiosurgery ensures an effective and safe long-term control of Koos grade IV vestibular schwannomas: a single-center, retrospective, cohort study	15
Stereotactic radiosurgery for patients with spinal metastases from prostate cancer	15
Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis	15
Impact of proton versus photon radiotherapy on overall survival in the management of spinal chordoma and mortality risk prediction: a nationwide analysis	14
Letter to the editor: surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study	14
Tissue biopsy before resection in glioblastoma: is there an opportunity to improve outcomes with liquid biopsies and pre-operative stereotactic radiosurgery?	14
Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes	14
High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer	14
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity	14
Targeting ataxia-telangiectasia mutated and cystine/glutamate antiporter enhances radiotherapy efficacy and tumor suppression in glioblastoma	14
Elevating the findings by substituting in “ISarcoPRM”	14
Factors associated with cognitive impairment in long-term IDH-mutant glioma survivors	14
Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis	14
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis	14
Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes	14
The 4S of spinal astrocytoma: specific location, syrinx, spasticity and score on Modified Mccormick Scale (MMS) predict long term outcomes in patients undergoing surgical resection of intramedullary s	14
Evaluating the role of gross total resection in primary spinal cord glioblastoma: evidence from a multicenter cohort and meta-analysis	14
Targeting COL5A1 enhances anoikis thus attenuating malignancy of glioblastoma via inhibiting the Wnt/β-catenin signaling pathway	13
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study	13
Correction to: Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions	13
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104	13
The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age	13
Anatomical changes in resection cavity during brain radiotherapy	13
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions	13
Standardizing connectome-based brain tumor surgery through a network-based surgical nomenclature	13
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion	13
Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions	13
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide	13
Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study	13
Postoperative stereotactic radiosurgery for intracranial solitary fibrous tumors: systematic review and pooled quantitative analysis	13
Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study	13
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449	13
Palliative care of older glioblastoma patients in neurosurgery	13
The role of MRI patterns in predicting neurologic deficits in spinal ependymomas	13
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws	13
Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR)	13
NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1	13
Study of prediction model for high-grade meningioma using fractal geometry combined with radiological features	13
Outcomes of radiation-induced meningiomas treated with stereotactic radiosurgery	12
Racial disparities in the management and outcomes of primary osseous neoplasms of the spine: a SEER analysis	12
Neuropsychological impairment in primary malignant brain tumor patients with awake craniotomy: a hospital-based registration study	12
The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients	12
Long-term outcomes of modern radiation therapy for pituitary adenoma – different techniques: single institute experience	12
Hypofractionated vs. conventional fractionated radiotherapy in the temozolomide era for elderly patients with glioblastoma: a systematic review and meta-analysis by the Korean Society for Neuro-Oncolo	12
The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues	12
Superficial meningioma with bone involvement: surgical strategies and clinical outcomes	12
Correction to: The characteristics of brain structural remodeling in patients with unilateral vestibular schwannoma	12

An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	12
Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center study	12
Patient-derived glioma organoids real time identification of IDH mutation, 1p/19q-codeletion and CDKN2A/B homozygous deletion with differential ion mobility spectrometry	12
Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion	12
Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study	12
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery	12
Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review	12
NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas	12
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis	12
Long-term outcomes of central neurocytoma – an institutional experience	11
Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response	11
Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study	11
Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?	11
Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort	11
The patients’ experience of neuroimaging of primary brain tumors: a cross-sectional survey study	11
Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial	11
Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma	11
ERK inhibition in glioblastoma is associated with autophagy activation and tumorigenesis suppression	11
Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM	11
Hematological adverse events in the management of glioblastoma	11
Comment on “Amino-acid PET as a prognostic tool after post-stupp protocol temozolomide therapy in high-grade glioma patients”	11
Large vestibular schwannoma treated using a cranial nerve sparing approach with planned subtotal microsurgical resection and stereotactic radiosurgery: meta-analysis and International Stereotactic Rad	11
High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI	11
Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center	11
Computerized assessment of neuropsychological functioning in pediatric brain tumor patients	11
Surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study	11
Resection of craniopharyngiomas: comparison between gross total resection and subtotal resection with adjuvant radiation	11
Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis	11
Repeated stereotactic radiosurgery for high grade meningioma	11
Short-term sensorimotor training incorporating cognitive tasks for pediatric survivors of posterior fossa tumors: a pilot study	11
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center	11
Impact of seizures and antiseizure medication on survival in patients with glioma	11
Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review	11
Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates	10
Frequency of and risk factors associated with local recurrence after spinal stereotactic body radiation therapy without surgery	10
Physical function, body mass index, and fitness outcomes in children, adolescents, and emerging adults with craniopharyngioma from proton therapy through five years of follow-up	10
Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification	10
Likelihood-of-harm/help of microsurgery compared to radiosurgery in large vestibular schwannoma	10
T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma	10
The magnitude of surgical site infection and its associated factors among pediatric central nervous system (CNS) tumor patients at tertiary referral hospitals in Ethiopia: a multi-center study	10
The association of hospital volume status with treatment and survival outcomes of intracranial meningioma patients: a multivariable analysis of the National Cancer Database	10
Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis	10
Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations	10
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol	10
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis	10
Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study	10
IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas	10
Tumor-related epilepsy in high-grade glioma: a large series survival analysis	10
Evaluation of clinical and volumetric outcomes following adaptive gamma knife radiosurgery for brain metastases	10
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study	10
Perilesional resection technique of glioblastoma: intraoperative ultrasound and histological findings of the resection borders in a single center experience	10
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningioma	10
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma	10
Stereotactic body radiation therapy for spinal metastases from gastrointestinal primary cancers	10
The cognitive functions and seizure outcomes of patients with low-grade epilepsy-associated neuroepithelial tumors	10
Regression of sporadic CNS hemangioblastomas with belzutifan	10
Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study	10
DNA damage in IDH-mutant gliomas: mechanisms and clinical implications	10
Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis	10
Meningioma in patients exposed to progestin drugs: results from a real-life screening program	10
Interstitial photodynamic therapy for newly diagnosed glioblastoma	10
MGMT promoter methylation in 1p19q-intact gliomas	10
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study	10
Additive risk of surgical site infection from more than one risk factor following craniotomy for tumor	10
Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatment	10
Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases	9
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience	9
Posterior fossa syndrome in a population of children and young adults with medulloblastoma: a retrospective, multicenter Italian study on incidence and pathophysiology in a histologically homogeneous	9
Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis	9
Collagen type I alpha 1 induces radio-resistance in hypoxic glioblastoma cells by promoting autophagy	9
Stereotactic radiosurgery for brain metastases: evolving practice patterns from the national cancer database (2004–2020)	9
Investigating the effects of PTEN mutations on cGAS-STING pathway in glioblastoma tumours	9
Non-navigated 2D intraoperative ultrasound: An unsophisticated surgical tool to achieve high standards of care in glioma surgery	9
Financial toxicity in patients with glioblastoma	9
Mental health status and associated factors of caregivers of patients with malignant brain tumors	9
Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients	9
Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles	9
Does preoperative gamma knife treatment affect the result of microresection of vestibular schwannoma?	9
Glioblastomas at the white matter of temporo-parietal junction cause a poor postoperative independence level	9
Correction to: Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma	9
The dynamic nature of frailty in metastatic spine disease patients	9
Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis	9
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review	9
Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3	9
Overexpression of LSR suppresses glioma proliferation and invasion via regulating FOXO3a	9
Magnetic resonance imaging signal characteristics associated with prognosis of skull base chordoma after gamma knife radiosurgery	9
Comparative analysis of hypofractionated short-course versus standard radiation therapy in elderly patients with glioblastoma: analysis of nationwide database	9
Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas	9
Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in Germany	9
Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 2018	9
Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience	9
The “Combo” radiotherapy treatment for high-risk grade 2 meningiomas: dose escalation and initial safety and efficacy analysis	9
Primary CNS lymphoma of the corpus callosum: presentation and neurocognitive outcomes	9
Long-term quality of life and hypothalamic dysfunction after craniopharyngioma	9
Peritumoral edema resolves infrequently in surgically treated patients with intracranial meningioma– a retrospective study of 279 meningioma patients	9